Find information on thousands of medical conditions and prescription drugs.

Graft versus host disease

Graft-versus-host disease is a common complication of allogeneic bone marrow transplantation. After bone marrow transplantation, T cells present in the graft, either as contaminants or intentionally introduced into the host, attack the tissues of the transplant recipient. Graft-versus-host disease can occur even when HLA-identical siblings are the donors. HLA-identical siblings or HLA-identical unrelated donors (called a minor mismatch as opposed to differences in the HLA antigens, which constitute a major mismatch) often still have genetically different proteins that can be presented on the MHC. more...

Home
Diseases
A
B
C
D
E
F
G
Galactorrhea
Galactosemia
Gardner's syndrome
Gastric Dumping Syndrome
Gastroesophageal reflux
Gaucher Disease
Gaucher's disease
Gelineau disease
Genu varum
Geographic tongue
Gerstmann syndrome
Gestational trophoblastic...
Giant axonal neuropathy
Giant cell arteritis
Giardiasis
Gigantism
Gilbert's syndrome
Gilles de la Tourette's...
Gingivitis
Gitelman syndrome
Glanzmann thrombasthenia
Glioblastoma
Glioblastoma multiforme
Glioma
Glomerulonephritis
Glossodynia
Glossophobia
Glucagonoma
Glucose 6 phosphate...
Glutaryl-CoA...
Glycogen storage disease
Glycogen storage disease...
Glycogen storage disease...
Glycogenosis type IV
Glycosuria
Goiter
Goldenhar syndrome
Goodpasture's syndrome
Graft versus host disease
Granulocytopenia
Graves' disease
Great vessels transposition
Growth hormone deficiency
Guillain-Barré syndrome
Gymnophobia
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Clinical and Diagnostic Pathology of Graft-versus-Host Disease $79.95 Irradiation of Blood Components $13.00
Pathology and Immunology of Transplantation and Rejection $247.31 Role of nitric oxide in graft versus host disease associated idiopathic pneumonia syndrome : (Dissertation) $55.00
Graft-Vs-host Disease $170.00 Talking Points in Dermatology - I (New Clinical Applications: Dermatology) $186.58
The role of TGF-beta-dependent CD103 expression in the pathogenesis of graft-versus-host disease : (Dissertation) $55.00 Graft-Versus-host Disease (Medical Intelligence Unit) $122.35
Current and Future Immunosuppressive Therapies Following Transplantation $36.89 Graft-Vs.-Host Disease: Immunology, Pathophysiology, and Treatment (Hematology) $48.00

Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation
Nine years after receiving a bone marrow transplant for aplastic anemia, a 14-year-old girl with severe pulmonary disease associated with graft-versus-host ...
Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation
The authors present three patients with severe GVHD not responding to treatment with steroids. The cohort of patients had developed grade II-IV GVHD ...
Pseudomembranous gastritis: A novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease
A 36-year-old Hispanic man who had undergone allogeneic bone marrow transplantation, complicated by graft versus host disease, was admitted with acute ...
Graft-versus-host disease in allogeneic bone marrow transplantation: The role of monoclonal antibodies in prevention and treatment
Abstract: Reconstitution of an individual's haemopoietic stem cells by bone marrow transplantation (BMT) is the recommended treatment for a number of haematological conditions, both malignant and non
Graft versus host disease in allogeneic bone marrow transplants
Introduction The American Leukemia Society reports that Graft Versus Host Disease (GVHD) affects approximately 50% of allogeneic bone marrow transplant ...
Studies of Nipent® in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease Presented at American
DUBLIN, Calif., Dec. 9 /PRNewswire-FirstCall/ -- SuperGen, Inc. announced that abstracts from five studies of its anticancer drug Nipent(R) (pentostatin ...
New Study Shows NOXAFIL® Oral Suspension Significantly Reduced Aspergillosis, Invasive Fungal Infections, Compared to Fluconazole, in Allogeneic
BERLIN, Oct. 25 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today reported results of a new clinical study demonstrating that its investigational ...
DOR BioPharma, Inc. Announces Top-Line Results of Pivotal Phase III Clinical Trial of orBec for Intestinal Graft-versus-Host Disease
MIAMI -- orBec(R) Demonstrates Highly Statistically Significant Reduction in Mortality and Positive Trend in Primary Endpoint DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company&

Home Contact Resources Exchange Links ebay